Soggetto:
Stefan Kaufmann ( Max Planck Institute, Berlin), on a new vaccine for TB
Stefan Kaufmann, director of Max Planck Institute for Infection Biology, in Berlin, and past president of IUIS explains the advantage on the new vaccine for TB his group is testing in clinical trials in Europe and Africa.
English
Read time: 1 minSubmitted by redazione on 11 September, 2013 - 08:16Immunology
Autori:
di redazione
Sezioni: